Trial Profile
Phase II/III maintenance study of AJG501 in patients with ulcerative colitis
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 17 Aug 2018
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Sponsors Ajinomoto Pharma
- 01 Jun 2016 New trial record